Literature DB >> 17118231

Anemia and diabetic nephropathy.

Eberhard Ritz1.   

Abstract

Anemia has recently been recognized as a frequent complication of diabetic nephropathy, appearing earlier than in nondiabetic renal disease and amplifying the risks of cardiovascular and microvascular complications. A major cause is an inappropriate erythropoietin response to anemia, often accompanied by iron deficiency and therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17118231     DOI： 10.1007/s11892-006-0081-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  46 in total

1.  Erythropoietin for neurologic protection and diabetic neuropathy.

Authors:  Stuart A Lipton
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Cardiac disease in diabetic end-stage renal disease.

Authors:  R N Foley; B F Culleton; P S Parfrey; J D Harnett; G M Kent; D C Murray; P E Barre
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy.

Authors:  S Inomata; M Itoh; H Imai; T Sato
Journal:  Nephron       Date:  1997       Impact factor: 2.847

5.  The relationship between hemoglobin levels and diabetic retinopathy.

Authors:  Q Qiao; S Keinänen-Kiukaanniemi; E Läärä
Journal:  J Clin Epidemiol       Date:  1997-02       Impact factor: 6.437

Review 6.  The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment.

Authors:  Peter A McCullough; Norman E Lepor
Journal:  Rev Cardiovasc Med       Date:  2005       Impact factor: 2.930

7.  Effect of erythropoietin therapy on polyneuropathy in predialytic patients.

Authors:  Kamal Hassan; Waleed Simri; Irina Rubenchik; Judith Manelis; Bella Gross; Shaul M Shasha; Batya Kristal
Journal:  J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.902

8.  Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.

Authors:  Anupama Mohanram; Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Barry M Brenner; Robert D Toto
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

9.  Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice.

Authors:  Kimio Satoh; Yutaka Kagaya; Makoto Nakano; Yoshitaka Ito; Jun Ohta; Hiroko Tada; Akihiko Karibe; Naoko Minegishi; Norio Suzuki; Masayuki Yamamoto; Masao Ono; Jun Watanabe; Kunio Shirato; Naoto Ishii; Kazuo Sugamura; Hiroaki Shimokawa
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

10.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112
View more
  3 in total

1.  Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy.

Authors:  Amra Mataradzija; Halima Resić; Senija Rasić; Nihad Kukavica; Fahrudin Masnić
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

2.  Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy.

Authors:  Xinyao Yi; Wenhui Yan; Tingli Guo; Na Liu; Zhuanzhuan Wang; Jia Shang; Xiaotong Wei; Xin Cui; Yuzhuo Sun; Shuting Ren; Lina Chen
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

3.  The Relationship between Anemia and the Initiation of Dialysis in Patients with Type 2 Diabetic Nephropathy.

Authors:  Sun Hee Kim; Kyung Ae Lee; Heung Yong Jin; Hong Sun Baek; Tae Sun Park
Journal:  Diabetes Metab J       Date:  2015-04-22       Impact factor: 5.376
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.